Annual Working Capital
$1.80 B
+$67.37 M+3.89%
31 December 2023
Summary:
CRISPR Therapeutics AG annual working capital is currently $1.80 billion, with the most recent change of +$67.37 million (+3.89%) on 31 December 2023. During the last 3 years, it has risen by +$176.93 million (+10.91%). CRSP annual working capital is now -21.69% below its all-time high of $2.30 billion, reached on 31 December 2021.CRSP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$1.85 B
-$28.50 M-1.51%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly working capital is currently $1.85 billion, with the most recent change of -$28.50 million (-1.51%) on 30 September 2024. Over the past year, it has increased by +$204.73 million (+12.41%). CRSP quarterly working capital is now -26.46% below its all-time high of $2.52 billion, reached on 30 June 2021.CRSP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | +12.4% |
| 3 y3 years | +10.9% | -23.5% |
| 5 y5 years | +310.2% | +217.3% |
CRSP Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.7% | +10.9% | -23.5% | +12.4% |
| 5 y | 5 years | -21.7% | +310.2% | -26.5% | +217.3% |
| alltime | all time | -21.7% | >+9999.0% | -26.5% | +1164.0% |
CRISPR Therapeutics AG Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.85 B(-1.5%) |
| June 2024 | - | $1.88 B(-5.9%) |
| Mar 2024 | - | $2.00 B(+11.2%) |
| Dec 2023 | $1.80 B(+3.9%) | $1.80 B(+9.1%) |
| Sept 2023 | - | $1.65 B(-4.5%) |
| June 2023 | - | $1.73 B(-2.0%) |
| Mar 2023 | - | $1.76 B(+1.7%) |
| Dec 2022 | $1.73 B(-24.6%) | $1.73 B(-2.8%) |
| Sept 2022 | - | $1.78 B(-10.3%) |
| June 2022 | - | $1.99 B(-7.4%) |
| Mar 2022 | - | $2.15 B(-6.6%) |
| Dec 2021 | $2.30 B(+41.6%) | $2.30 B(-5.2%) |
| Sept 2021 | - | $2.42 B(-3.9%) |
| June 2021 | - | $2.52 B(+44.1%) |
| Mar 2021 | - | $1.75 B(+7.8%) |
| Dec 2020 | $1.62 B | $1.62 B(+24.1%) |
| Sept 2020 | - | $1.31 B(+46.6%) |
| June 2020 | - | $891.11 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $874.20 M(-6.0%) |
| Dec 2019 | $930.44 M(+112.1%) | $930.44 M(+59.2%) |
| Sept 2019 | - | $584.29 M(+43.5%) |
| June 2019 | - | $407.06 M(-3.4%) |
| Mar 2019 | - | $421.40 M(-3.9%) |
| Dec 2018 | $438.65 M(+87.6%) | $438.65 M(-5.5%) |
| Sept 2018 | - | $464.41 M(+48.8%) |
| June 2018 | - | $312.07 M(-7.4%) |
| Mar 2018 | - | $337.08 M(+44.1%) |
| Dec 2017 | $233.87 M(-21.6%) | $233.87 M(-5.1%) |
| Sept 2017 | - | $246.47 M(-7.2%) |
| June 2017 | - | $265.47 M(-5.0%) |
| Mar 2017 | - | $279.55 M(-6.3%) |
| Dec 2016 | $298.19 M(+103.3%) | $298.19 M(+94.2%) |
| Sept 2016 | - | $153.55 M(-8.9%) |
| June 2016 | - | $168.56 M(+14.9%) |
| Dec 2015 | $146.69 M(<-9900.0%) | $146.69 M |
| Dec 2014 | -$1.18 M | - |
FAQ
- What is CRISPR Therapeutics AG annual working capital?
- What is the all time high annual working capital for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual working capital year-on-year change?
- What is CRISPR Therapeutics AG quarterly working capital?
- What is the all time high quarterly working capital for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly working capital year-on-year change?
What is CRISPR Therapeutics AG annual working capital?
The current annual working capital of CRSP is $1.80 B
What is the all time high annual working capital for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual working capital is $2.30 B
What is CRISPR Therapeutics AG annual working capital year-on-year change?
Over the past year, CRSP annual working capital has changed by +$67.37 M (+3.89%)
What is CRISPR Therapeutics AG quarterly working capital?
The current quarterly working capital of CRSP is $1.85 B
What is the all time high quarterly working capital for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly working capital is $2.52 B
What is CRISPR Therapeutics AG quarterly working capital year-on-year change?
Over the past year, CRSP quarterly working capital has changed by +$204.73 M (+12.41%)